Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

WEHI991 drug target identification by DIA Solvent PISA

ABSTRACT: Here we demonstrate PfSTART1 engagement by WEHI991 in the P. falciparum proteome using organic solvent-based Proteome Integral Solubility Alteration (Solvent PISA) assay coupled with Data Independent Acquisition Mass Spectrometry (DIA-MS).

ORGANISM(S): Plasmodium (plasmodium)

SUBMITTER: Jerzy Dziekan

PROVIDER: PXD048262 | JPOST Repository | Wed May 01 00:00:00 BST 2024

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Similar Datasets

Improved drug-target deconvolution with PISA-DIA using an extended, overlapping temperature gradient

Project description:For target-engagement applications, a comparative analysis was performed to assess the suitability, ease of implementation and cost-effectiveness between Cellular Thermal Shift Assay (CETSA) and Proteome Integral Solubility Alteration (PISA). Human multiple myeloma cells U266B1 cell lysate was treated with either 1 μM BCL-XL inhibitor or DMSO as a vehicle to perform i) label-free PISA approach to analyse each PISA pool by data-independent acquisition (DIA) approach (PISA-DIA-MS) and ii) traditional TMT labelled proteome-wide CETSA approach (CETSA-TMT-MS).

2024-05-20 | PXD044545 | Pride

Elstera litoralis strain:Dia-1

Project description:Elstera litoralis strain:Dia-1 Genome sequencing and assembly

| PRJNA278930 | ENA

scRNAseq RAT DIA WT and DMD 12months

Project description:scRNAseq RAT DIA WT and DMD 12months

| PRJNA814255 | ENA

Drug-target of DNA methyltransferase inhibitors

Project description:Malaria eradication requires the development of new drugs to combat drug-resistant parasites. The search for new chemical scaffolds that target novel pathways of the human malaria parasite Plasmodium falciparum is of highest priority. We identified bisbenzylisoquinoline alkaloids isolated from Cocculus sp. (trilobine derivatives) as active in the nanomolar range against P. falciparum blood stages. Synthesis of a library of 94 hemi-synthetic derivates allowed us to identify compound 84 (c-84) that kills multi-drug resistant clinical isolates in the nanomolar range (median IC50 ranging from 35-88nM). Efforts were made to obtain compounds with significantly improved preclinical properties. Out of those, compound 125 (c-125) delays the onset of parasitemia in P. berghei infected mice and inhibits P. falciparum transmission stages in vitro (culture assays) and in vivo using membrane feeding assay in the Anopheles stephensi vector. C-125 also impairs P. falciparum development in sporozoite-infected hepatocytes, in the low micromolar range. Finally, we used a chemical pull-down to identify potential protein targets of this chemical family. Our mass spectrometry analysis identified the parasite interactome with trilobine alkaloid, allowing us to identify protein partners belonging to metabolic pathways that have not been previously targeted by antimalarial drugs or implicated in drug-resistance mechanisms in malaria parasites.

2023-01-01 | PXD036288 | Pride

ProteomicAnalysis(DIA)ofmuscleinvasivebladdercancerpatient-derivedxenografts

Project description:Accesstoproteomicfiles(DIA)ofMIBCpatient-derivedxenografts(N=8)

| EGAD00010002512 | EGA

Proteomicanalysis(DIA)ofpatientswithnon-muscleinvasiveandmuscleinvasivebladdercancer

Project description:Accesstoproteomicfiles(DIA)ofpatientswithtreatment-naiveMIBC(N=51),treatment-naiveNMIBC(N=17)andneoadjuvantMIBC(N=11)

| EGAD00010002513 | EGA

Benchmark Dataset DIA Clinical Proteomics LymphNodes E.coli

Project description:Real patient variability Benchmark Dataset for Optimization of DIA data analysis workflows

| EGAD00010002223 | EGA

DNA damage regulation and its role in drug-related phenotypes in the malaria parasites. [RNA]

Project description:The goal of our study is to characterize the global transcriptional resposne of P.falciparum to DNA damageing agents. Alongside, we stidied the epigenetic regulation of DNA damage resposne in parasite. Further, we studied the mecanism which underlined the ARMD (mutator) phenotype of P. falciparum. In order to elucidate the transcriptiona resposne to DNA damage, P. falciparum 3D7 parasites were treated with 4 perturbating agents for 6 hours. We mapped the global nucleosome occupancy for 3 most responsive histone modifications to DNA damage by chromatin immunoprecipitation coupled with DNA microarray (ChIP-on-chip). In order to identify the transcriptional similarities between artemesinin and MMS, we carried out 6 hours of artemesinin treatment in triplicates and compared with triplicate dataset of MMS.

2016-06-01 | E-GEOD-72578 | biostudies-arrayexpress

DNA damage regulation and its role in drug-related phenotypes in the malaria parasites. [genomic DNA]

2016-06-01 | E-GEOD-72579 | biostudies-arrayexpress

A comprehensive spectral assay library to quantify the Halobacterium salinarum NRC-1 proteome by DIA/SWATH-MS

Project description:Data-Independent Acquisition (DIA) is a mass spectrometry-based method to reliably identify and reproducibly quantify large fractions of a target proteome. The peptide-centric data analysis strategy employed in DIA requires a priori generated spectral assay libraries. Such assay libraries allow to extract quantitative data in a targeted approach and have been generated for human, mouse, zebrafish, E. coli and few other organisms. However, a spectral assay library for the extreme halophilic archaeon Halobacterium salinarum NRC-1, a model organism that contributed to several notable discoveries, is not publicly available yet. Here, we report a comprehensive spectral assay library to measure 2,563 of 2,646 annotated H. salinarum NRC-1 proteins. We demonstrate the utility of this library by measuring global protein abundances over time under standard growth conditions. The H. salinarum NRC-1 library includes 21,074 distinct peptides representing 97% of the predicted proteome and provides a new, valuable resource to confidently measure and quantify any protein of this archaeon.

2023-09-21 | PXD042770 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data